These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 6314582

  • 1. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K.
    Thromb Haemost; 1983 Aug 30; 50(2):552-6. PubMed ID: 6314582
    [Abstract] [Full Text] [Related]

  • 2. [Hemophilia and HTLV-III infection].
    Lechler E.
    Z Hautkr; 1986 Dec 01; 61(23):1687-704. PubMed ID: 2949442
    [Abstract] [Full Text] [Related]

  • 3. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W, Muntean W, Teubl I, Beaufort F, Heinz FX.
    Padiatr Padol; 1987 Dec 01; 22(1):33-41. PubMed ID: 3108827
    [Abstract] [Full Text] [Related]

  • 4. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H.
    Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759
    [Abstract] [Full Text] [Related]

  • 5. Sequential clinical and immunologic abnormalities in hemophiliacs.
    Goldsmith JM, Kalish SB, Green D, Chmiel JS, Wallemark CB, Phair JP.
    Arch Intern Med; 1985 Mar 03; 145(3):431-4. PubMed ID: 3919666
    [Abstract] [Full Text] [Related]

  • 6. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C, Gervais F, Fuks A, Guttmann RD, Strawczynski H, Shuster J, Gold P.
    Can Med Assoc J; 1983 Oct 01; 129(7):713-7. PubMed ID: 6225504
    [Abstract] [Full Text] [Related]

  • 7. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP, Janot C, Briquel ME, André E, Schooneman F, Vigneron C, Legras B, Alexandre P, Streiff F.
    Pathol Biol (Paris); 1985 Dec 01; 33(10):951-6. PubMed ID: 3005949
    [Abstract] [Full Text] [Related]

  • 8. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G, Böttiger B, Karlsson A, Sandström E, Morfeldt-Månsson L, Blombäck M, Nilsson IM, Wiechel B, Saxinger C, Gallo R.
    Cancer Res; 1985 Sep 01; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [Abstract] [Full Text] [Related]

  • 9. Immunologic studies in asymptomatic hemophiliac patients.
    Frydecka I, Kowalewska B, Lesiecki A, Kuliczkowski K, Palakowska A, Polkowski A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Sep 01; 113(5):708-15. PubMed ID: 2435638
    [Abstract] [Full Text] [Related]

  • 10. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T.
    AIDS Res; 1986 Dec 01; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [Abstract] [Full Text] [Related]

  • 11. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R, Veitch SE, Edmond E, Peutherer JF, Prescott RJ, Steel CM, Ludlam CA.
    Lancet; 1984 Jun 30; 1(8392):1431-4. PubMed ID: 6145879
    [Abstract] [Full Text] [Related]

  • 12. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
    Lopaciuk S, Kacperska E, Gloskowska-Moraczewska Z, Maslanka K, Uhrynowska M, Kraj M, Seyfried H.
    Thromb Haemost; 1987 Feb 03; 57(1):41-3. PubMed ID: 3495899
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS, Bettelheim P, Köller U, McDougal S, Graninger W, Luger TA, Knapp W, Lechner K.
    J Clin Invest; 1985 Jun 03; 75(6):1828-34. PubMed ID: 2989334
    [Abstract] [Full Text] [Related]

  • 14. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT, Roach J, Cheek-Luten M, Ruymann FB.
    Diagn Immunol; 1986 Jun 03; 4(1):37-42. PubMed ID: 3006971
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P, Mariani G, Mannucci PM, De Rossi G, Nicoletti L, Titti F, Falcione E, Pasqualetti D, Ammassari M, Gringeri A.
    J Med Virol; 1986 Jun 03; 19(2):143-9. PubMed ID: 3014059
    [Abstract] [Full Text] [Related]

  • 16. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM, van der Meer J, Smit JW, Halie MR.
    Thromb Haemost; 1993 Apr 01; 69(4):306-10. PubMed ID: 8388579
    [Abstract] [Full Text] [Related]

  • 17. Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.
    Gjerset GF, McGrady G, Counts RB, Martin PJ, Jason J, Kennedy S, Evatt B, Hansen JA.
    Blood; 1985 Sep 01; 66(3):718-20. PubMed ID: 2992642
    [Abstract] [Full Text] [Related]

  • 18. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL, Vermylen J, Colaert J, Desmyter J, Gautama K, Stevens E, The AL, Vanham G, Vermylen C, Verstraete M.
    Thromb Haemost; 1984 Apr 30; 51(2):207-11. PubMed ID: 6429883
    [Abstract] [Full Text] [Related]

  • 19. Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate.
    Unzeitig JC, Church JA, Gomperts ED, Nye CA, Pasquale S, Richards W.
    Am J Dis Child; 1984 Jul 30; 138(7):645-8. PubMed ID: 6233901
    [Abstract] [Full Text] [Related]

  • 20. Impaired distribution of T-lymphocyte subsets in patients with haemophilia.
    Lauria F, Guerrini L, Magni E, Mancino A, Monti G, Raspadori D.
    Boll Ist Sieroter Milan; 1984 May 31; 63(2):145-9. PubMed ID: 6331833
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.